Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
clinical data show that 80% of patients report significant improvement by week three
Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders, and that GLP-1 receptor agonists show potential for treating people with alcohol use disorder (AUD)
Y., Zin, M
.png.jpg)
This estimate decreased to a null value after confounding factors were accounted for (hazard ratio 1.02, 95% CI 0.85 to 1.23)
US$ 28.35
US$ 25.39
US$ 24.85
